A Community-Driven Hub for Life Sciences News and Discovery In an era of rapid scientific progress and near-constant breakthroughs, having a reliable, inclusive platform to share and explore life-sciences news is more important than ever. Life Science Daily News...
The U.S. Food and Drug Administration released its official list of novel drug approvals for 2025, marking a year of significant therapeutic breadth and scientific innovation. Novel drugs are defined as new molecular entities or biologics approved for use in the...
The life sciences industry is advancing at a speed that would have felt unimaginable just a few years ago. Artificial intelligence is shortening drug discovery timelines. Digital therapeutics are reshaping care delivery. Precision medicine is moving healthcare from...
As 2026 begins, it is natural to pause and reflect on the year behind us while thinking about what lies ahead. In the life sciences, these reflections often centre on progress: new experiments to launch, collaborations to build, technologies to adopt, or ideas to...
Walking around 7,000 steps each day could help sharpen cognition and shield against a variety of chronic illnesses, according to a major new analysis. This target may be more attainable, yet still effective, than the widely publicised 10,000 step goal. Published in...
Concerns are mounting that the United Kingdom’s official appraisal framework is systematically underestimating the economic and social value of investments in life sciences manufacturing. Industry bodies and independent analysts warn that the methods used to evaluate...
The Crown Estate has completed the acquisition of Harwell East, a 221 acre site adjacent to the Harwell Science and Innovation Campus in Oxfordshire. The development could deliver up to 4.5 million square feet of laboratory, research, manufacturing and office space,...
Amazon is gearing up to roll out prescription kiosks inside One Medical clinics in Los Angeles beginning December 2025. These in office machines will allow patients to collect common prescription medications such as antibiotics, inhalers, and treatments for high blood...
A new multi cancer blood test developed by the United States biotechnology company Grail has demonstrated in North America the ability to detect a wide range of cancers, including many for which no screening programmes exist, at an early and potentially treatable...
Eli Lilly & Company is doubling down on U.S. investment, unveiling a series of ambitious plans to expand its domestic pharmaceutical manufacturing infrastructure. These efforts come amid mounting political pressure to reshore drug production and rising competition...
In late September 2025, former U.S. President Donald J. Trump revived a series of controversial health claims and policy proposals concerning women especially pregnant women and children, triggering sharp pushback from medical experts, public health authorities, and...
The NHS in England is leading the world as the first healthcare system to introduce a pioneering ‘trojan horse’ therapy for patients with blood cancer, offering the potential to delay disease progression nearly three times longer than current treatment options....